超声引导下小针刀治疗跖筋膜炎临床疗效观察

目的 :探讨超声引导下小针刀疗法与传统针刀疗法治疗跖筋膜炎的临床疗效。方法 :自2011年3月至2015年5月,将234例诊断为跖筋膜炎的患者分为超声引导组和传统针刀组。超声引导组117例,男54例,女63例;年龄42~81岁,平均(54.36±15.04)岁;病程平均(15.72±9.55)个;采用超声引导下小针刀疗法进行治疗。传统针刀组117例,男52例,女65例;年龄43~80岁,平均(53.59±18.14)岁;病程平均(16.98±8.99)个;不采用超声引导、仅使用传统针刀技术进行治疗。观察并比较两组治疗前,治疗1周、1个月和3个月后视觉模拟评分(VAS)、压痛评分及美国足踝外科协会后足评分(AOFAS-AH)。结果:两组患者治疗1周、1个月、3个月后的VAS评分、压痛评分,超声引导组均低于传统针刀组,差异具有统计学意义(P0.05),超声引导组在减轻患者疼痛方面疗效优于传统针刀组,且起效更快;治疗1周、1个月、3个月后的AOFAS-AH评分超声引导组均高于传统针刀组,差异有统计学意义(P0.05),超声引导组患者术后各时段足的功能优于传统针刀组;两组患者术后伤口愈合情况均较好,无并发症发生。结论:超声引导下小针刀技术是治疗跖筋膜炎的可靠方法,具有起效快、疗效优、功能恢复良好的优点。     

改良手法牵伸配合针刀松解为主治疗跟骨骨刺综合征的病例对照研究

目的:观察改良跖筋膜牵伸手法配合针刀松解为主治疗跟骨骨刺综合征的临床疗效,并探讨此方法的优点。方法:将115例2010年9月至2015年9月诊断为跟骨骨刺综合征患者分为2组,治疗组58例,男21例,女37例;年龄26~73岁,病程6~51个月;采用改良手法牵伸配合针刀松解治疗。对照组57例,男22例,女35例;年龄31~75,病程7~58个月;采用常规牵伸手法配合针刀松解。分别于治疗后1周、1个月和3个月进行足跟痛NRS评分,采用"Foot and Ankle Ability Measure(FAAM)"量表对两组患者进行疗效评价。结果:治疗组治疗后1、3个月,疼痛NRS评分3.89±0.96,2.46±0.95,均优于对照组的4.52±1.21,4.73±1.11;治疗组FAAM得分率(3.89±0.96)%,(2.46±0.95)%,均优于对照组的(4.52±1.21)%,(4.73±1.11)%;总体疗效治疗组优于对照组。结论:改良跖筋膜牵伸手法配合针刀松解能定位牵伸力点,对跟骨骨刺综合征患者疗效显著,相比传统牵伸手法配合针刀松解有较高的中远期疗效。     

骶尾手法治疗骶尾痛的病例对照研究

目的 :观察骶尾手法治疗尾骨痛的临床疗效。方法 :自2013年11月至2015年7月,共纳入184例骶尾痛患者,分为治疗组及对照组。治疗组男26例,女65例,平均年龄(39.63±11.62)岁;对照组男31例,女62例,平均年龄(41.47±11.56)岁。治疗组采用骶尾手法治疗,每周治疗3次,2周为1个疗程。对照组外用双氯芬酸二乙胺乳胶剂涂抹,每日2次,2周为1个疗程。在病例筛选入组的当天及之后第2、7、14天和治疗后3个月的5个时间点进行临床观察。通过比较两组的VAS疼痛分值、骶尾痛评分表分值和压痛程度等评价骶尾手法的疗效。结果:骶尾痛VAS分值的组内比较,两组均从第2天开始差异有统计学意义。随访各时点VAS差值的组间比较,治疗组大于对照组,从第2天开始两组差异有统计学意义。随访各时点骶尾痛评分表总分差值的组间比较,治疗组大于对照组,从第2天开始两组差异有统计学意义。随访各时点压痛程度的组间比较,从第2天开始两组差异有统计学意义。结论:骶尾手法能够明显改善骶尾部疼痛症状,治疗骶尾痛的疗效优于双氯芬酸二乙胺乳胶剂,且作用效果更明显。     

冲击波联合富血小板血浆治疗跖筋膜炎的临床研究

目的探讨发散式体外冲击波疗法(extracorporeal shock wave therapy,ESWT)与富血小板血浆(platelet rich plasma,PRP)联合治疗慢性跖筋膜炎的临床疗效。方法前瞻性单中心随机对照研究,选取2017年1月至2018年12月因足跟痛于重庆大学附属三峡医院就诊并诊断为慢性跖筋膜炎的患者60例,其中男性19例,女性41例;年龄20~68岁,平均(44.56±10.68)岁。依照随机数字表法分为ESWT治疗组(E组)、PRP治疗组(P组)和ESWT-PRP联合治疗组(联合组),每组20例。比较三组患者治疗前及治疗结束后4、12、24周视觉模拟评分(visual analogue scale,VAS)、改良足功能指数(revised footfunction index,FFI-R)。分别于治疗前及治疗结束后24周采用超声测量跖筋膜厚度。结果三组患者一般资料及治疗前VAS评分、FFI-R评分比较差异无统计学意义(P>0.05),治疗结束后VAS评分、FFI-R评分均较治疗前明显改善(P<0.05)。4周时联合组及E组优于P组(P<0.05),24周时联合组及P组优于E组(P<0.05)。治疗结束24周后三组患者跖筋膜厚度较治疗前均有明显改善(P<0.05),相关性分析发现VAS评分与跖筋膜厚度存在正相关性。所有患者均未出现严重不良反应。结论采用发散式ESWT与PRP联合方案治疗慢性跖筋膜炎安全、有效、起效快、并发症少、治疗效果维持时间长,值得临床研究与推广。     

剪切波超声弹性成像技术在颈肩肌筋膜疼痛综合征中的应用

目的 :探讨剪切波超声弹性成像技术在颈肩肌筋膜疼痛综合征中的应用。方法 :选取2013年12月至2014年7月临床诊断为颈肩肌筋膜疼痛综合征的患者30例(病例组)及对照组30例(健康人群)。病例组男17例,女13例,平均年龄(44±3)岁;对照组男22例,女8例,平均年龄(37±5)岁。病例组患者行手法治疗,隔日1次,共7次,分别以剪切波超声弹性成像技术检测病例组患者治疗前后斜方肌紧张处,以及对照组斜方肌降部肌腹,记录并比较组织弹性图和杨氏模量值,对结果进行统计分析。结果:病例组治疗前斜方肌组织弹性图以绿蓝色为主,弹性评分3.70±1.53,杨氏模量值(43.4±15.6)k Pa;治疗后组织弹性图以蓝色为主,弹性评分2.40±0.87,杨氏模量值(29.0±5.9)k Pa;对照组组织弹性图以蓝色为主,弹性评分1.60±0.72,杨氏模量值(24.0±7.6)k Pa;三者两两比较,P=0.000,差异均有统计学意义。结论:剪切波超声弹性成像技术可作为检测中医手法治疗颈肩肌筋膜疼痛综合征疗效的客观检测方法,且较敏感。     

奇正青鹏膏剂外用治疗类风湿关节炎止痛消肿作用的临床对照试验

目的：评价奇正青鹏膏剂外用对类风湿关节炎关节疼痛肿胀的临床疗效。方法：自2004年12月至2006年5月采用随机、平行对照临床研究方案,运用区组随机化方法,利用SAS软件的PROCPLAN语句,将78例患者随机分为治疗组和对照组。治疗组40例,男30例,女10例,平均年龄（48.2±9.7）岁,用奇正青鹏膏剂外用治疗;对照组38例,男30例,女8例,平均年龄（47.7±13.7）岁,用双氯芬酸二乙胺乳胶剂外用。以掌指关节中肿痛最重的一个关节作为观察关节,观察关节疼痛、关节压痛、关节肿胀、关节屈伸不利、晨僵等情况,根据尼莫地平法计算症状积分指数（VAS记分）,进行疗效判定。结果：共有68例完成试验,治疗组35例,对照组33例。治疗2周末治疗组显效1例,有效27例,无效7例;对照组显效2例,有效20例,无效11例,两组疗效差异无统计学意义。但治疗1周末治疗组关节肿胀的评分为（4.0±1.4）分,低于对照组的（5.5±1.9）分。结论：奇正青鹏膏剂治疗类风湿性关节炎与双氯芬酸二乙胺乳胶剂缓解关节疼痛疗效相当,奇正青鹏膏剂消肿作用更强。     

非手术综合治疗颈椎病的康复效果

目的 探讨微机控制牵引加TDP、双氯芬酸二乙胺乳膏治疗颈椎病康复效果及作用机制.方法院320例颈椎病患者随机分为2组.对照组157例,予常规理疗;治疗组163例,在常规理疗基础上采用微相控制牵引加TDP照射、双氯芬酸二乙胺乳膏外涂.结果 对照组愈显率61.1％、总有效率82.8％;治疗组愈显率85.9％、总有效康98.8％.经统计学分析,治疗组效优于对照组(P＜0.01),治疗组平均住院天数缩短(P＜0.01).结论 微机控制牵引加TDP、双氯芬酸二乙胺乳膏治疗颈椎病效果明显,缩短病程.     

超声引导下富血小板血浆注射治疗足底筋膜炎的疗效观察

目的观察超声引导下局部注射富血小板血浆(PRP)与类固醇激素治疗足底筋膜炎的临床疗效。方法选择2016年6月至2017年3月就诊于本院疼痛科的足底筋膜炎患者32例,男9例,女23例,年龄36～73岁,BMI 18～35kg/m2。随机分为超声引导下富血小板血浆注射治疗组(PRP组)和超声引导下类固醇激素注射治疗组(S组),每组16例。在超声引导下PRP组将制备出的4ml PRP注入跖筋膜表面。S组将复方倍他米松1ml+2%盐酸利多卡因注射液2ml的混合液注入跖筋膜表面。评估患者注射治疗前(T0)和治疗后1个月(T1)、3个月(T2)、6个月(T3)时晨起后起步状态、步行10步后状态和当天总体平均状态的VAS评分。采用超声测量T0和T2时患者俯卧位时跟骨-筋膜结合处足底筋膜厚度。观察注射部位有无出血、血肿、感染以及足底筋膜有无撕裂等并发症。结果与T0时比较,T1、T2和T3时两组患者晨起后起步状态、步行10步后状态和当天总体平均状态VAS评分均明显降低(P0.05)。与S组比较,T1和T2时PRP组晨起后起步状态、步行10步后状态和当天总体平均状态VAS评分明显升高(P0.05),T3时PRP组晨起后起步状态、步行10步后状态和当天总体平均状态VAS评分明显降低(P0.05)。与T0时比较,T2时两组足底筋膜厚度明显变薄(P0.05),T0和T2时两组足底筋膜厚度差异无统计学意义。两组患者治疗后均未发现出血、血肿、感染以及足底筋膜撕裂等并发症。结论超声引导下局部注射富血小板血浆与类固醇激素均能有效治疗足底筋膜炎,激素局部注射显效快,但富血小板血浆疗效相对更稳定持久。     

超声引导下微创治疗急性肩峰三角肌下滑囊炎的病例对照研究

目的 :评价超声引导下微创治疗急性肩峰三角肌下滑囊炎的疗效。方法 :对2012年6月至2014年3月肩痛患者进行肌骨超声检查,诊断为急性肩峰三角肌下滑囊炎120例,分为治疗组和对照组。治疗组60例,男28例,女32例,平均年龄(56.31±8.23)岁,病程(8.08±1.32)d,采用肌骨超声引导下注射治疗;对照组57例,男24例,女33例,平均年龄(57.39±9.25)岁,病程(7.74±1.29)d,采用病变部位痛点封闭治疗。对患者治疗前后肩关节疼痛、夜间静息痛及功能、二次注射率和综合疗效进行观察评估。结果:两组治疗后肩关节疼痛、夜间静息痛及功能均较治疗前改善,治疗1 d、1周后两组VAS评分对比,治疗组优于对照组;治疗1 d后夜间静息痛治疗组优于对照组;治疗1 d、1周及1个月后两组功能评分比较,治疗组高于对照组。二次注射人数治疗组13例,低于对照组45例。两组综合疗效评定,治疗组痊愈37例,优于对照组21例。结论:超声引导下微创治疗急性肩峰三角肌下滑囊炎较传统封闭疗法起效更快,疗程更短,短期疗效及综合疗效优于传统封闭疗法。     

经皮微创跖筋膜松解联合跟骨减压治疗跖筋膜炎12例北大核心CSCD

目的探讨经皮微创跖筋膜松解联合跟骨减压治疗保守治疗无效的跖筋膜炎的临床疗效。方法2018年1月~2019年12月对12例保守治疗无效的跖筋膜炎足跟内侧经皮做一小切口,微创下行跖筋膜松解,切断跖筋膜内侧1/2,同时在足跟压痛点处以2.0 mm克氏针垂直跟骨骨面钻孔,进行局部减压。术前后采用疼痛视觉模拟评分(Visual Analogue Scale,VAS)、美国足踝外科协会踝-后足(American Orthopaedic of Foot and Ankle Surgery Ankle-Hindfoot,AOFAS-AH)评分及足与踝预后量表(Foot and Ankle Outcome Scale,FAOS)进行评估。结果术后切口均一期愈合,均未发生血管神经损伤、感染等并发症。12例术后随访6~12个月,(9.2±1.7)月。VAS评分由术前(7.9±0.3)分,改善为末次随访时(1.5±0.2)分(P=0.000)。AOFAS-AH评分由术前(48.9±1.2)分,提高到末次随访时(82.5±0.7)分(P=0.000)。FAOS评分由术前(42.2±0.8)分,提高到末次随访(82.6±1.1)分(P=0.000)。结论经皮微创跖筋膜松解联合跟骨减压术可有效缓解保守治疗无效的跖筋膜炎症状,创伤小,恢复快。     

Investigation of the relationship between the thickness of the plantar calcaneonavicular ligament and plantar fascia in patients with plantar fasciitis

BackgroundAlthough patients with plantar fasciitis show spring ligament laxity, the thickness of the spring ligament in patients with plantar fasciitis remains unclear. This study aimed to elucidate the morphological characteristics of the spring ligament in patients with plantar fasciitis based on an ultrasound imaging system (US).MethodsThirty feet of 30 patients (painful group) diagnosed with plantar fasciitis at our hospital and thirty feet of 30 healthy volunteers (healthy group) without plantar pain were investigated. The thicknesses of both the spring ligament and plantar fascia were assessed via a US statistical comparison of the spring ligament and plantar fascia thickness between the painful and healthy groups. This was performed using Welch’s t-test, and the significance level was set at p < 0.01. In addition, Pearson’s correlation coefficient was calculated to assess the correlation between the spring ligament and plantar fascia thickness in the two groups, and the significance level was set at p < 0.01.ResultsThe spring ligament thickness in the painful group was significantly lower than that in the healthy group (p < 0.001). The thickness of the plantar fascia in the painful group was significantly greater than that in the healthy group (p = 0.03). In addition, the correlation between the spring ligament and plantar fascia thickness was moderately negative (r = −0.42, p = 0.001). The thicker the plantar fascia in the subjects, the thinner was the spring ligament.ConclusionsThe thickness of the spring ligament in patients with plantar fasciitis decreased. The thinning of the spring ligament was negatively correlated with the thickening of the plantar fascia as per the US evaluation. Based on the spring ligament thinning determined via US evaluation, interventions such as insoles from an early stage could prevent the onset of plantar fasciitis.     

吊单杠锻炼在肩背部肌筋膜炎防治中作用的临床对照试验

目的：探讨一种防治肩背部肌筋膜炎的功能锻炼方法。方法：2006年8月至2008年3月治疗120例肩背部肌筋膜炎患者,随机分为治疗组60例与对照组60例,对照组中男39例,女21例;平均年龄（47．0±12．0）岁;病程平均为（14．1±12．0）个月。治疗组中男41例,女19例;平均年龄为（43．7±9．9）岁;病程平均为（16．4±13．4）个月。两组分别采用推拿与推拿合吊单杠锻炼治疗,治疗3周后评价疗效。随访6～26个月,观察复发情况。结果：治疗3周后,患者疼痛、肩背沉重感、条索状改变、压痛、肩背功能5项指标的评分相对于治疗前明显改善,差异均有统计学意义（P〈0．01）。治疗后治疗组与对照组这5项指标的差异也具有统计学意义（P〈0．05）。对照组的复发率高于治疗组（P〈0．01）。结论：在肩背部肌筋膜炎的治疗中加入吊单杠锻炼可以提高治疗效果,坚持锻炼又可以起到较好地预防复发的作用,值得临床推广。     

Magnetic Resonance Imaging and Clinical Outcomes of Laser Therapy,Ultrasound Therapy,and Extracorporeal Shock Wave Therapy for Treatment of Plantar Fasciitis: A Randomized Controlled Trial

We determined and compared the effectiveness of low-level laser therapy (LLLT), therapeutic ultrasound (US) therapy, and extracorporeal shock wave therapy (ESWT) using magnetic resonance imaging (MRI). We performed a randomized, prospective, comparative clinical study. A total of 60 patients with a diagnosis of chronic plantar fasciitis were divided randomly into 3 treatment groups: group 1 underwent 15 sessions of LLLT (8 J/cm²; 830 nm); group 2 underwent 15 sessions of continuous US (1 mHz; 2 W/cm²); and group 3 underwent 3 sessions of ESWT (2000 shocks). All patients were assessed using the visual analog scale (VAS), heel tenderness index (HTI), American Orthopaedic Foot and Ankle Society (AOFAS) ankle-hindfoot scale, Roles–Maudsley score, and MRI before and 1 month after treatment. The primary efficacy success criterion was the percentage of decrease in heel pain of >60% from baseline at 1 month after treatment for ≥2 of the 3 heel pain (VAS) measurements. Significant improvement was measured using the mean VAS, AOFAS scale, and HTI scores for all 3 groups. The thickness of the plantar fascia had decreased significantly on MRI in all 3 groups. The treatment success rate was 70.6% in the LLLT group, 65% in the ESWT group, and 23.5% in the US group. LLLT and ESWT proved significantly superior to US therapy using the primary efficacy criterion (p = .006 and p = .012, respectively), with no significant difference between the LLLT and ESWT groups (p > .05). The treatment of chronic plantar fasciitis with LLLT and ESWT resulted in similar outcomes and both were more successful than US therapy in pain improvement and functional outcomes.     

Ultrasonographic evaluation of plantar fasciitis after low-level laser therapy: results of a double-blind, randomized, placebo-controlled trial

The aim of this study was to investigate the effect of low-level laser therapy (LLLT) on plantar fasciitis documented by the ultrasonographic appearance of the aponeurosis and by patients’ pain scores. Thirty individuals with diagnosis of unilateral plantar fasciitis were enrolled in a randomized, double-blind, placebo-controlled trial, but 25 participants completed the therapeutic protocol. The contralateral asymptomatic fascia was used as control. After enrolment, symptomatic individuals were randomly assigned to receive LLLT, or identical placebo, for 6 weeks. Ultrasonography was performed at baseline and after completion of therapy. The subjective subcalcaneal pain was recorded at baseline and after treatment on a visual analogue scale (VAS). After LLLT, plantar fascia thickness in both groups showed significant change over the experimental period and there was a difference (before treatment and after treatment) in plantar fascia thickness between the two groups. However, plantar fascia thickness was insignificant (mean 3.627 ± 0.977 mm) when compared with that in the placebo group (mean 4.380 ± 1.0042 mm). Pain estimation on the visual analogue scale had improved significantly in all test situations (after night rest, daily activities) after LLLT when compared with that of the placebo group. (P = 0.006 and P = 0.01, respectively). Additionally, when the difference in pain scores was compared between the two groups, the change was statistically significant (after night rest P = 0.000; daily activities P = 0.001). In summary, while ultrasound imaging is able to depict the morphologic changes related to plantar fasciitis, 904 nm gallium–arsenide (GaAs) infrared laser may contribute to healing and pain reduction in plantar fasciitis.     

The short-term effect after a single injection of high-molecular-weight hyaluronic acid in patients with enthesopathies (lateral epicondylitis,patellar tendinopathy,insertional Achilles tendinopathy,and plantar fasciitis): a preliminary study

BackgroundHyaluronic acid (HA) with a high molecular weight of 2700 kDa is approved in Japan to treat osteoarthritis of the knee, periarthritis scapulohumeralis, and knee pain associated with rheumatoid arthritis. The purpose of this preliminary study was to investigate the short-term efficacy, safety, and injectable volume of HA in the treatment of enthesopathies.MethodsA total of 61 patients (16 with lateral epicondylitis, 14 with patellar tendinopathy, 15 with insertional Achilles tendinopathy, and 16 with plantar fasciitis) were each administered a single injection of HA (up to 2.5 ml). Efficacy and safety were assessed by comparing the visual analog scale (VAS) for pain and local symptoms before injection (baseline) and at 1 week after injection. We also investigated the injectable volume by means of the difference in syringe weight before and after injection and by the judgment of the administering investigator.ResultsThe injection of HA resulted in a change in VAS (mean ± SD) of −2.20 ± 2.26 cm for the four sites overall and −2.55 ± 2.43 cm for lateral epicondylitis, −2.01 ± 2.16 cm for patellar tendinopathy, −1.80 ± 1.91 cm for insertional Achilles tendinopathy, and −2.38 ± 2.61 cm for plantar fasciitis. The injection of HA also improved local symptoms in each site. It was also determined that 2.5 ml of HA can be injected in each of the four sites.ConclusionA single injection of HA resulted in similar improvements of pain in each of the four enthesopathies (lateral epicondylitis, patellar tendinopathy, insertional Achilles tendinopathy, and plantar fasciitis). These results suggest that HA could be clinically effective in the treatment of enthesopathies.     

Impact of plantar fasciitis on postural control and walking in young middle-aged adults

PurposeTo assess if plantar fasciitis has an impact on postural control and walking pattern from gait analysis across different experimental conditions.MethodsThirty participants (n = 15 with plantar fasciitis) performed 5 different balance tasks on a force platform, and the center of pressure (COP) was computed for postural control analysis. Participants were also asked to walk at 3 different speeds on a gait analysis system to compute the spatial-temporal parameters. Clinical foot measurements (pain, mobility) were also collected through all participants.ResultsClinical foot measurements showed no significant difference between the two groups; except for pain palpation in plantar fasciitis group. Significant differences were observed between the two groups for COP area displacement sway (p < 0.01; d = 0.08) and velocity (p = 0.022; d = 0.04), where the fasciitis group reported poorer postural control than control mainly during more challenging balance tasks (semi-tandem, unipodal). Plantar fasciitis group reported a decrease of gait velocity (p < 0.01; d = 0.12), step length (p < 0.01; d = 0.16) and step width (p < 0.01; d = 0.18) when compared to the healthy group across walking speed tests.ConclusionsIndividuals with plantar fasciitis report poor postural control and changes in walking pattern across three speeds performance.     

Ultrasonographic evaluation at 6-month follow-up of plantar fasciitis after extracorporeal shock wave therapy

Introduction The aim of this study was to investigate the effect of extracorporeal shock wave therapy (ESWT) on the ultrasonographic appearance of chronically painful, proximal plantar fasciitis.Materials and methods Twenty-two patients with a unilateral proximal plantar fasciitis were prospectively enrolled after unsuccessful conservative treatment lasting 6 months. The contralateral plantar fascia was used as the control. ESWT (3×3000 shock waves/session of 0.2 mJ/mm²) was performed at weekly intervals. The thickness of the plantar fascia was measured ultrasonographically about 2 cm distal of the medial calcaneal tuberosity. Pain estimation on a visual analogue scale (VAS) and the comfortable walking time were recorded. No local anaesthesia was applied. Follow-up was done at 6, 12 and 24 weeks.Results Before ESWT, the plantar fasciitis side was ultrasonographically significantly thicker than the control side (p<0.05), whereas 6 months after ESWT, the thickness of the fascia was no longer significantly different. The decrease in thickness of the plantar fasciitis side was significant (p<0.05). Pain during activities of daily living decreased by 79% according to the VAS, and the comfortable walking time increased, both significantly (p<0.01). In patients with little pain (VAS<30), the thickness of the plantar fasciitis side was significantly less (p<0.01) compared with patients who still suffered more pain (VAS>30).Conclusion After ESWT, the thickness of the plantar fascia in patients with plantar fasciitis decreased, pain and walking time improved (all significantly).     

Platelet-rich plasma injections for chronic plantar fasciitis

Purpose

The purpose of this study was to assess the safety and preliminary clinical results of platelet-rich plasma (PRP) injections for treating chronic plantar fasciitis.

Methods

Fourteen consecutive patients with chronic plantar fasciitis receiving three injections of PRP into the plantar fascia were assessed 12 months after the procedure. The modified Roles and Maudsley score and a visual analogue scale (VAS) for pain were used to evaluate the clinical results.

Results

According to criteria of the Roles and Maudsley score, at 12 months of follow-up, results were rated as excellent in nine (64.3 %), good in two (14.3 %), acceptable in two (14.3 %) and poor in one (7.1 %) patient. VAS for pain was significantly decreased from 7.1?±?1.1 before treatment to 1.9?±?1.5 at the last follow-up (p?<?0.01).

Conclusions

In this single-centre, uncontrolled, prospective, preliminary study, results indicate that treating chronic plantar fasciitis with PRP injections is safe and has the potential to reduce pain.